Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

APOMORPHINE vs APREPITANT: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

APOMORPHINE vs APREPITANT: Safety Overview

Metric APOMORPHINE APREPITANT
Total FAERS Reports 7,957 5,620
Deaths Reported 372 1,195
Death Rate 4.7% 21.3%
Hospitalizations 1,002 2,917
Average Patient Age 69.2 yrs 52.8 yrs
% Female Patients 38.3% 70.9%
FDA Approval Date Apr 20, 2004 Dec 17, 2015
Manufacturer TruPharma, LLC Heron Therapeutics, Inc.
Route SUBCUTANEOUS INTRAVENOUS
Marketing Status Discontinued Prescription